ANDAINJECTIONINJECTABLE
Approved
Sep 2008
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
TECHNETIUM TC 99M SESTAMIBI (technetium tc 99m sestamibi) by Curium Pharma is radiopharmaceutical activity [moa]. First approved in 2008.
Drug data last refreshed 20h ago
Mechanism of Action
Radiopharmaceutical Activity
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Curium Pharma
France - Paris
Worked on TECHNETIUM TC 99M SESTAMIBI at Curium Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.